Alkermes

$22.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.56 (-2.45%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Alkermes and other stocks, options, and ETFs commission-free!

About ALKS

Alkermes plc Ordinary Shares, also called Alkermes, is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland. The listed name for ALKS is Alkermes plc Ordinary Shares.

CEO

Richard F. Pops

Employees

2,235

Headquarters

Dublin, Dublin

Founded

2011

Market Cap

3.55B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.66M

High Today

$23.02

Low Today

$22.03

Open Price

$22.57

Volume

1.87M

52 Week High

$23.02

52 Week Low

$11.98

Collections

Analyst Ratings

10%

of 10 ratings

Buy

10%

Hold

80%

Sell

10%

ALKS Earnings

-$0.21

$0.14

$0.48

$0.83

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 11, Pre-Market